Project Grant HT94252510172
Award Date
4/1/25
Completion Date
3/31/28
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
The Regents of the University of Michigan received a $312,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 2-year grant, awarded on February 1, 2024, supports research to investigate "An Unexpected Role for the Ubiquitin Proteasome System in Repeat Associated Non-AUG Translation." This basic and translational biomedical research aims to advance understanding and treatment of neurological...
The Defense Health Agency awarded a $1,178,939.00 Project Grant to the Regents of the University of Michigan under the Military Medical Research and Development program (CFDA 12.420) to conduct advanced phenotyping research to improve diagnostic, longitudinal assessment, and treatment strategies for deployment-related respiratory disease. The award period is from September 1, 2023 to August 31, 2026. As a U.S. Government Entity and top public research university, the University of Michigan...
The Defense Health Agency awarded a $607,377 Project Grant to the Regents of the University of Michigan to fund a 2-year research project titled "A NEW IDEA FOR ADVANCING AXITINIB-BASED THERAPY IN RECURRENT AND METASTATIC HNSCC." This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public. The University of Michigan, a leading...
This $1,404,000.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan, Office of Research and Sponsored Projects (doing business as the University of Michigan) on September 1, 2023. The funding will support research to target the lipid kinase PIKfyve in neuroendocrine prostate cancer over a 3-year period ending on August 31, 2026. The University of Michigan is a leading...
The University of Michigan was awarded a $624,000 Cooperative Agreement by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program. The award, titled "UNIVERSITY OF MICHIGAN PHASE 1/2 CLINICAL TRIALS ASSESSMENT IN KIDNEY CANCER THERAPEUTICS (U-MPAKT)", will fund research and clinical trials to assess new therapies for kidney cancer. The project will take place over a 2-year period from September 2024 to September 2026. This award is...
The University of Michigan will receive $1.2 million from the Defense Health Agency under a three-year Project Grant award for research titled "FADD: A Mechanistic Basis and Therapeutic Opportunity for Overcoming CDK4/6 Inhibitor Resistance." The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for...
The University of Michigan received a $925,834 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into CDK12 as a context-specific tumorigenesis regulator and novel therapeutic target in castration-resistant prostate cancer. The research will be performed in Ann Arbor, Michigan over a three-year period from September 2021 through August 2024. Through the support of basic,...
The University of Michigan will receive $304,472 over two years through a Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research into regulating prostate skeletal bone metastases through TIM-3-dependent efferocytosis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative and...
This Project Grant from the Defense Health Agency provides $8,351,133 to the Regents of the University of Michigan from May 1, 2023 to April 30, 2027. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to investigate the pivotal and diverse roles of matricellular proteins in musculoskeletal disorders.
The University of Michigan will conduct the primary research. Two subawards totaling $XXX,XXX were also issued to support complementary work....